Connect with us

Industry

UK cannabis firm Avida Global acquires leading CBD producer

Avida Global has announced its takeover of Canna Creations and Green Stem CBD

Published

on

UK cannabis firm Avida Global
Avida Global has announced its takeover of Canna Creations and Green Stem CBD

British cannabis firm Avida Global has announced its takeover of Canna Creations and Green Stem CBD.

The acquisition sees the firm become a fully vertically integrated seed-to-sale business, now controlling the entire lifecycle of its medical cannabis oils.

White-labelling manufacturing business, Canna Creations, produces a wide range of CBD products for several high-street retailers, and Green Stem CBD is its own brand, one of only four CBD brands currently available on Amazon, and is stocked in Boots and other high street retailers.

Founder Brett Horth, will take up the position of Avida Global CEO, Australia, New Zealand and Asia and join the Avida Global board with immediate effect.

Nathan Whitman, CEO of Canna Creations and Green Stem CBD will assume the position of MD of Avida Global Labs and Green Stem CBD.

Avida Global CEO, David Kirby, commented: “The acquisition of Canna Creations and Green Stem CBD to Avida Global marks a transformative milestone in our plans to create an innovative fully integrated seed-to-sales business.

“Both are high-quality brands in keeping with our own philosophy, and we are already building on our various synergies to create exciting opportunities globally.

“The addition of Brett Horth and Nathan Whitman to the Avida Global team is hugely exciting. They are both dynamic cannabis and CBD veterans and a bring a wealth of experience with them and a shared desire to benefit patients, customers and shareholders.”

Canna Creations will be rebranded to Avida Global Labs whilst Green Stem CBD will retain its name.

Horth commented: “I am incredibly excited not only for the opportunity for Green Stem CBD to be presented on the global stage as part of Avida Global, and being an intrinsic part of a fully vertical operation, but also for the new opportunities that await as CEO of Avida Global Australia, New Zealand and Asia.”

Whitman added: “I am honoured to join a world-class team of cannabis experts within Avida’s Global network. Canna Creations and Green Stem CBD will benefit in the now established vertical operation which enhances our in-house formulation and testing capabilities, bringing affordable premium products to a global market.”

Sarah Sinclair is an award-winning freelance journalist covering health, drug policy and social affairs. She is one of the few UK reporters specialising in medical cannabis policy and as the former editor of Cannabis Health has covered developments in the European cannabis sector extensively, with a focus on patients and consumers. She continues to report on cannabis-related health and policy for Forbes, Cannabis Health and Business of Cannabis and has written for The i Paper, Byline Times, The Lead, Positive News, Leafie & others. Sarah has an NCTJ accreditation and an MA in Journalism from the University of Sunderland and has completed additional specialist training through the Medical Cannabis Clinicians Society in the UK. She has spoken at leading industry events such as Cannabis Europa.

Trending

Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2024 PP Intelligence Ltd.